A1 Journal article – refereed
Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?




List of Authors: Landini L, Honka MJ, Ferrannini E, Nuutila P
Publisher: BENTHAM SCIENCE PUBL LTD
Publication year: 2016
Journal: Current Pharmaceutical Design
Journal name in source: CURRENT PHARMACEUTICAL DESIGN
Journal acronym: CURR PHARM DESIGN
Volume number: 22
Issue number: 1
ISSN: 1381-6128

Abstract


Obesity, a chronic low-grade inflammation disorder characterized by an expansion in adipose tissue mass, is rapidly expanding worldwide leading to an increase in the incidence of comorbidities such as insulin resistance, type 2 diabetes and cardiovascular diseases. This has led to a renewed interest in the adipose tissue function, historically considered as a passive fat storage. It is now well established that adipose tissue is an organ with an active role in production and release of a variety of molecules called adipocytokines. Dysregulated production of adipocytokines seems to be responsible for the pathogenesis of insulin resistance and type 2 diabetes; however, the mechanisms are still unclear. Hypoxia, that occurs when adipocytes expand in obesity, has been proposed as a possible cause of adipose tissue inflammation. On the other hand, recent studies have shown that adipose tissue oxygen tension was actually higher (hyperoxia) than normal and associated with insulin resistance in obesity, despite a reduction in blood flow. This might be explained by the role of mitochondria' oxygen consumption. Hence, further studies are needed to understand the role of adipose tissue oxygenation and perfusion in obesity to assess pathophysiology and novel opportunities for treating the diseases.


Last updated on 2019-21-08 at 22:17